Self-administration With Uniject Of The Once-a-month Injectable Contraceptive Cyclofem.

dc.creatorBahamondes, L
dc.creatorMarchi, N M
dc.creatorNakagava, H M
dc.creatorde Melo, M L
dc.creatorCristofoletti, M de L
dc.creatorPellini, E
dc.creatorScozzafave, R H
dc.creatorPetta, C
dc.date1997-Nov
dc.date2015-11-27T12:19:04Z
dc.date2015-11-27T12:19:04Z
dc.date.accessioned2018-03-29T00:52:26Z
dc.date.available2018-03-29T00:52:26Z
dc.identifierContraception. v. 56, n. 5, p. 301-4, 1997-Nov.
dc.identifier0010-7824
dc.identifier
dc.identifierhttp://www.ncbi.nlm.nih.gov/pubmed/9437558
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/194083
dc.identifier9437558
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1294316
dc.descriptionThe objective of this study was to evaluate women's acceptance of and ability to self-administrate the injectable contraceptive Cyclofem using prefilled UniJect devices. A total of 102 women were invited to participate in the study. Fourteen women (13.7%) refused to participate. Of the remaining 88 women, 32 women (31.4%) consented to participate and were trained using oranges but were still afraid of the procedure and ultimately refused to self-administer the injections. Only 56 women (55%) ultimately self-injected Cyclofem with UniJect. They performed a total of 144 injections, all of them on the ventral side of the thigh. When nurses evaluated women's ability to activate the devices, they found that more than 80% were successful in both the group of women that later self-administered the injections and the group that did not. The evaluation of the self-administered injection technique showed that more than 90% of the women correctly self-administered the contraceptive using UniJect. With respect to the opinion of the women about the self-administration of the contraceptive, more than 50% (32 of 56) of women who self-injected preferred to self-administer the injection and said that they wished to continue with the self-administration, one-third (17) reported that they were afraid, and seven women (12.5%) expressed the opinion that the injection in the thigh was more painful than the administration in the buttocks or arm. In conclusion, our study showed that women can be trained to successfully self-administer the monthly injectable contraceptive Cyclofem and generally respond positively to UniJect.
dc.description56
dc.description301-4
dc.languageeng
dc.relationContraception
dc.relationContraception
dc.rightsfechado
dc.rights
dc.sourcePubMed
dc.subjectBrazil
dc.subjectContraceptive Agents, Female
dc.subjectContraceptives, Oral, Combined
dc.subjectEstradiol
dc.subjectEvaluation Studies As Topic
dc.subjectFemale
dc.subjectHumans
dc.subjectInjections
dc.subjectMedroxyprogesterone Acetate
dc.subjectPatient Satisfaction
dc.subjectSelf Administration
dc.subjectTime Factors
dc.subjectAcceptors--women
dc.subjectAmericas
dc.subjectBrazil
dc.subjectClinical Research
dc.subjectContraception
dc.subjectContraceptive Agents
dc.subjectContraceptive Agents, Estrogen
dc.subjectContraceptive Agents, Female
dc.subjectContraceptive Agents, Progestin
dc.subjectContraceptive Methods
dc.subjectContraceptive Usage
dc.subjectDeveloping Countries
dc.subjectEquipment And Supplies
dc.subjectFamily Planning
dc.subjectFamily Planning Programs
dc.subjectInjectables
dc.subjectLatin America
dc.subjectMedroxyprogesterone Acetate
dc.subjectMethod Acceptability
dc.subjectResearch Methodology
dc.subjectResearch Report
dc.subjectSouth America
dc.subjectSyringe
dc.titleSelf-administration With Uniject Of The Once-a-month Injectable Contraceptive Cyclofem.
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución